Indian Court seeks clarity on price regulator's action
This article was originally published in Scrip
Executive Summary
The controversial price caps case in India appears to be at a significant juncture with the Delhi High Court seeking clarity on the National Pharmaceutical Pricing Authority's (NPPA) action that capped medicine prices under a 'public interest' provision.